Quantum-Si (QSI) Scheduled to Post Quarterly Earnings on Thursday

Quantum-Si (NASDAQ:QSI) will announce its earnings results after the market closes on Thursday, November 9th. Investors interested in participating in the company’s conference call can do so using this link.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings results on Monday, August 7th. The company reported ($0.18) earnings per share for the quarter. The company had revenue of $0.21 million for the quarter.

Quantum-Si Price Performance

Shares of NASDAQ:QSI opened at $1.19 on Thursday. The stock has a market cap of $168.65 million, a P/E ratio of -1.45 and a beta of 2.79. The firm has a fifty day moving average price of $1.77 and a 200 day moving average price of $1.91. Quantum-Si has a 1-year low of $1.12 and a 1-year high of $3.90.

Institutional Investors Weigh In On Quantum-Si

Institutional investors have recently bought and sold shares of the stock. Captrust Financial Advisors purchased a new stake in Quantum-Si in the first quarter valued at approximately $28,000. Royal Bank of Canada lifted its position in Quantum-Si by 210.4% during the second quarter. Royal Bank of Canada now owns 15,861 shares of the company’s stock valued at $29,000 after buying an additional 10,751 shares in the last quarter. Jane Street Group LLC acquired a new position in Quantum-Si during the third quarter valued at approximately $31,000. Principal Financial Group Inc. lifted its position in Quantum-Si by 35.8% during the second quarter. Principal Financial Group Inc. now owns 17,926 shares of the company’s stock valued at $42,000 after buying an additional 4,730 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its position in Quantum-Si by 87.6% during the third quarter. Alliancebernstein L.P. now owns 19,700 shares of the company’s stock valued at $54,000 after buying an additional 9,200 shares in the last quarter. 30.71% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the stock. Canaccord Genuity Group reiterated a “hold” rating and issued a $2.00 price objective (down previously from $3.50) on shares of Quantum-Si in a research note on Monday, September 25th. Canaccord Genuity Group downgraded shares of Quantum-Si from a “buy” rating to a “hold” rating and dropped their target price for the company from $3.50 to $2.00 in a report on Monday, September 25th.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of protein detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Carbon automated sample preparation instrument; the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip; the Quantum-Si Cloud data analysis software; and reagent kits for use with its instruments.